GlassScriptPhysician profile
Samuel C Borcherding
NPI 1366971442
$591.08
in general payments reported to CMS, 2019-2025
17 companies · $14.34 in 2025
The $14.34 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.22 · 2020: $11.59 · 2021: $114 · 2022: $263 · 2023: $162 · 2025: $14.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $102.80 | 2019-2025 | Arexvy, Shingrix |
| Abbvie INC. | $71.84 | 2021-2023 | Vraylar |
| E.R. Squibb & Sons, L.L.C. | $65.08 | 2021-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $48.65 | 2021-2022 | |
| Lilly USA, LLC | $48.01 | 2021-2023 | Mounjaro |
| Novo Nordisk INC | $43.75 | 2022-2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $26.73 | 2022-2023 | Gardasil 9, Vaqta, M-M-R II |
| Biohaven Pharmaceutical Holding Company LTD. | $23.55 | 2022 | |
| Abbott Laboratories | $21.85 | 2022 | |
| Idorsia Pharmaceuticals US INC | $21.51 | 2023 | Quviviq |
| Dexcom, INC. | $21.24 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $20.95 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.22 | 2022 | |
| Exact Sciences Corporation | $15.15 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $14.44 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.11 | 2022 | |
| Antares Pharma, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Borcherding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.